Skip to content
Sign in

BTAL · ARCA · ETF

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) Price, Holdings & Fees

$625.32−1.35%−$8.54End-of-day price as of Oct 9, 2026

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) closed at $625.32 on Oct 9, 2026, down 1.35% from the previous close of $633.86.

Share price, past year

1Y −1.98%

52-week range $584.37 – $680.46. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$625.32
Sep 30, 2026$646.03
Aug 31, 2026$644.42
Jul 31, 2026$631.29
Jun 30, 2026$613.65
May 29, 2026$594.11
Apr 30, 2026$618.86
Mar 31, 2026$632.79
Feb 27, 2026$665.12
Jan 30, 2026$652.46
Dec 31, 2025$616.33
Nov 28, 2025$650.94
Oct 31, 2025$636.12

Key statistics

Expense ratio
1.40%
as of Oct 31, 2025
Net assets
$282.9M
as of Jun 30, 2026
Holdings
405
as of Jun 30, 2026
52-week range
$584.37 – $680.46

AGF U.S. Market Neutral Anti-Beta Fund's expense ratio is 1.40%: $140.00 a year on $10,000 invested.

Holdings

AGF U.S. Market Neutral Anti-Beta Fund held 405 investments worth $282.86M as of Jun 30, 2026. Its largest holding was Okta, Inc., at 0.63% of the fund.

AGF U.S. Market Neutral Anti-Beta Fund largest holdings by share of net assets
#Holding% of fundValue
1Okta, Inc.0.63%$1.80M
2Molina Healthcare, Inc.0.53%$1.50M
3Rivian Automotive, Inc.0.51%$1.45M
4Cardinal Health, Inc.0.51%$1.44M
5AbbVie, Inc.0.50%$1.40M
6Simpson Manufacturing Co., Inc.0.49%$1.38M
7Cloudflare, Inc.0.48%$1.37M
8DaVita, Inc.0.48%$1.35M
9Lucid Group, Inc.0.48%$1.35M
10Teledyne Technologies, Inc.0.48%$1.35M
11CCC Intelligent Solutions Holdings, Inc.0.47%$1.34M
12Travelers Cos., Inc. (The)0.47%$1.34M
13Progressive Corp. (The)0.47%$1.33M
14Allstate Corp. (The)0.47%$1.32M
15Cognex Corp.0.47%$1.32M
16RLI Corp.0.46%$1.32M
17Commerce Bancshares, Inc.0.46%$1.31M
18Dynatrace, Inc.0.46%$1.31M
19A O Smith Corp.0.46%$1.30M
20Hanover Insurance Group, Inc. (The)0.46%$1.30M
21Brown & Brown, Inc.0.46%$1.30M
22Aramark0.46%$1.30M
23Ball Corp.0.46%$1.29M
24Cencora, Inc.0.46%$1.29M
25Fastenal Co.0.46%$1.29M

Top 25 of 405 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

AGF U.S. Market Neutral Anti-Beta Fund holdings by asset type
Asset type% of fund
Stocks2.79%
Derivatives−2.41%
AGF U.S. Market Neutral Anti-Beta Fund holdings by country, largest 10
Country% of fund
Ireland1.09%
Bermuda0.72%
Switzerland0.39%
Guernsey0.33%
Netherlands0.31%
United States0.30%
Curaçao−0.30%
Liberia−0.45%
United Kingdom−0.99%
Cayman Islands−1.03%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, AGF U.S. Market Neutral Anti-Beta Fund's total return was −19.86%, as reported to the SEC.

AGF U.S. Market Neutral Anti-Beta Fund monthly total returns
MonthTotal return
Jun 30, 2026−2.78%
May 31, 2026−7.93%
Apr 30, 2026−10.47%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
AGF U.S. Market Neutral Anti-Beta Fund
Ticker
BTAL
Exchange
ARCA
Fund type
ETF
Trust
AGF Investments Trust
SEC series ID
S000033013
SEC CIK
0001479599
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by AGF Investments Trust, the trust behind AGF U.S. Market Neutral Anti-Beta Fund, and cover all of its funds.

Frequently asked questions

What is BTAL's price?

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) closed at $625.32 on Oct 9, 2026, down 1.35% from the previous close of $633.86.

What is BTAL's expense ratio?

AGF U.S. Market Neutral Anti-Beta Fund's expense ratio is 1.40%: $140.00 a year on $10,000 invested.

What does BTAL hold?

AGF U.S. Market Neutral Anti-Beta Fund held 405 investments worth $282.86M as of Jun 30, 2026. Its largest holding was Okta, Inc., at 0.63% of the fund. Its five largest holdings were Okta, Inc., Molina Healthcare, Inc., Rivian Automotive, Inc., Cardinal Health, Inc., AbbVie, Inc..

How has BTAL performed?

Over the 3 months to Jun 30, 2026, AGF U.S. Market Neutral Anti-Beta Fund's total return was −19.86%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 19, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Oct 31, 2025. Prices are generated sample data for development. Data sources and disclosures